Amgen (nasdaq: AMGN - news - people ) faced achorusofprotest from patients and doctors after it stopped developing a medicine for Parkinson's disease because of its onerous side effects.
Washington's request was met by achorusofprotest, particularly from Greek ship owners who claim that America needs to know only who is in day-to-day control ofa vessel, not the name of the beneficial owner.